Sotabase

Career

· Researcher in the Singh Lab, Princeton University Laboratory for Intelligent Probabilistic Systems2025–

Publications (355)

Biliary complications following liver transplantation.
World Journal of Gastroenterology · 2013
166
cited
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
American Journal of Gastroenterology · 2018
152
cited
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group.
The Lancet Gastroenterology and Hepatology · 2020
118
cited
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology · 2018
116
cited
Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study
Gastroenterology · 2020
107
cited
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
The Lancet Gastroenterology and Hepatology · 2021
102
cited
Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients.
Journal of Crohn's & Colitis · 2012
89
cited
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
The Lancet Gastroenterology and Hepatology · 2020
84
cited
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
The Lancet Gastroenterology and Hepatology · 2021
77
cited
Capnographic Monitoring in Routine EGD and Colonoscopy With Moderate Sedation: A Prospective, Randomized, Controlled Trial
American Journal of Gastroenterology · 2016
71
cited
Old vs new: Risk factors predicting early onset colorectal cancer
World Journal of Gastrointestinal Oncology · 2019
69
cited
Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group.
Gastrointestinal Endoscopy · 2019
69
cited
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Inflammatory Bowel Diseases · 2018
67
cited
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clinical Gastroenterology and Hepatology · 2019
67
cited
Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
Inflammatory Bowel Diseases · 2018
64
cited
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Clinical Gastroenterology and Hepatology · 2020
63
cited
Can a validated sleep apnea scoring system predict cardiopulmonary events using propofol sedation for routine EGD or colonoscopy? A prospective cohort study.
Gastrointestinal Endoscopy · 2014
61
cited
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
Alimentary Pharmacology and Therapeutics · 2020
59
cited
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Clinical Gastroenterology and Hepatology · 2019
57
cited
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
American Journal of Gastroenterology · 2022
57
cited
Sotabase